SearchDictionaryMobileLogin

Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.

AuthorsM G Tektonidou, F N Skopouli
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2006 Mar-Apr Vol. 24 Issue 2 Suppl 41 Pg. S103 ISSN: 0392-856X Italy
PMID16859607 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Monoclonal
  • Immunologic Factors
  • rituximab
Topics
  • Adult
  • Antibodies, Antineutrophil Cytoplasmic (analysis)
  • Antibodies, Monoclonal (therapeutic use)
  • Female
  • Humans
  • Immunologic Factors (therapeutic use)
  • Remission Induction
  • Time Factors
  • Wegener Granulomatosis (complications, drug therapy, immunology)